FH and renal cell carcinoma: Although fumarate itself significantly distinguished FH-MT from FH-WT RCC and its plasma levels correlated with tumor burden (Figure 2B), because of its high variability and presence in NC samples, it was insufficiently sensitive to be used as a classifier (with ROCAUC = 0.86).